cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ Emerging opportunities for nicotinamide N-methyltransferase (NNMT) clinical translation Frontiers | Nicotinamide N-methyltransferase (NNMT):
Frontiers Nicotinamide N methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect Roles of Nicotinamide N Methyltransferase in Obesity and Type 2 Diabetes PMC Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target Heavy chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs Scientific Reports Complex roles of nicotinamide N methyltransferase in cancer progression PMC
Pay in 4 interest-free payments of $5.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12





